0
0.0
Mar 27, 2024
03/24
by
BBCNEWS
tv
eye 0
favorite 0
quote 0
numerous studies show that mifepristone, which was first approved by the fda in 2000, is safe. a study in the medical journaljama found that the number of self—managed abortions obtained using pills has soared with more than 26,000 americans using pills to induce at—home abortions after the overturing of roe v wade injune 2022. one of the things the justices spent a lot of time on today was not what we think of is the heart of the case, which was the fda's decision to expand access to mifepristone in 2016 and 2021, but instead on whether or not the challenges in this case, who are doctors and physicians groups whose members are opposed to abortion, have a legal right to come to court at all to challenge the fda's approval. you know, on two levels. first of all, whether or not someone can come to court to sue is sort of a bipartisan issue. it is something that justices of all ideological transfer attention to. it would also offerjustices and offramp to send this case back, to throw it out, without having to get to the heart of the case, the tougher question about the fda's a
numerous studies show that mifepristone, which was first approved by the fda in 2000, is safe. a study in the medical journaljama found that the number of self—managed abortions obtained using pills has soared with more than 26,000 americans using pills to induce at—home abortions after the overturing of roe v wade injune 2022. one of the things the justices spent a lot of time on today was not what we think of is the heart of the case, which was the fda's decision to expand access to...
0
0.0
Mar 26, 2024
03/24
by
BBCNEWS
tv
eye 0
favorite 0
quote 0
so it's about what the fda did, this is _ live. so it's about what the fda did, this is the _ live. so it's about what the fda did, this is the food _ live. so it's about what the fda did, this is the food and - live. so it's about what the fda did, this is the food and drug i did, this is the food and drug administration, it's about the specifics on that and the way that it loosened restrictions, right? that's correct. the original case was based on faulty signs. one of the studies that the plaintiffs used has since been retracted. the original case did try in a post—roe v wade world further restrict abortion by going after the abortion pill mifepristone. a question before the court now is less about the original fda approval of mifepristone and more about the specific contours of its access and legality in the provision of that drug now in the us. however, to have the supreme court taking up another abortion case so quickly after they overturned roe v wade signals alarm for the many americans, the majority of americans who want to see abortion remain legal. it of americans who w
so it's about what the fda did, this is _ live. so it's about what the fda did, this is the _ live. so it's about what the fda did, this is the food _ live. so it's about what the fda did, this is the food and - live. so it's about what the fda did, this is the food and drug i did, this is the food and drug administration, it's about the specifics on that and the way that it loosened restrictions, right? that's correct. the original case was based on faulty signs. one of the studies that the...
0
0.0
Mar 26, 2024
03/24
by
BBCNEWS
tv
eye 0
favorite 0
quote 0
fda's outsourcing of abortion drug harm to respondent doctors forces them to choose between helping a woman with a life—threatening condition and violating their conscience. the millions of americans have used mifepristone to safely end their pregnancies. respondents may not agree with that choice, but that doesn't give them article three standing or a legal basis to upend the regulatory scheme. for me, this really is the big one. if the court ruled against the fda, then potentially this would have far greater practical effects than dobbs did, because so many people are using this drug even in states where abortion is banned. but from what i picked up today from those oral arguments, it looks like the justices are seeking an off ramp. it does, and you bring up a really good point about if the rule this issue with this drug, there could be widespread ramifications. ithink one of the key issues in this case is standing. so in the united states, in order to bring a case, you have to have standing and you have to have some type of arm or injury —— harm or injury. and i think that'll
fda's outsourcing of abortion drug harm to respondent doctors forces them to choose between helping a woman with a life—threatening condition and violating their conscience. the millions of americans have used mifepristone to safely end their pregnancies. respondents may not agree with that choice, but that doesn't give them article three standing or a legal basis to upend the regulatory scheme. for me, this really is the big one. if the court ruled against the fda, then potentially this...
0
0.0
Mar 27, 2024
03/24
by
BBCNEWS
tv
eye 0
favorite 0
quote 0
fda approved it upon the scientificjudgement the drug is safe and speak —— effective. it has maintained that judgement across five administrations and many have usedit administrations and many have used it to safety end pregnancies. respondents may not e.g. —— agree to that choice but that does not give them a reason to uphold the scheme. ., ., , scheme. ruling against respondents _ scheme. ruling against respondents on - scheme. ruling againstl respondents on standing scheme. ruling against - respondents on standing he would — respondents on standing he would allow federal agencies to conscription unregulated parties violating consciences and suffering other harm without _ and suffering other harm withoutjudicial and suffering other harm without judicial recourse. around the world and across the uk. this is bbc news. let's look at some other stories making news. two government ministers have resigned in a double blow to rishi sunak, who was forced to carry out a mini—reshuffle of his team. robert halfon unexpectedly quit as skills, apprenticeships and higher e
fda approved it upon the scientificjudgement the drug is safe and speak —— effective. it has maintained that judgement across five administrations and many have usedit administrations and many have used it to safety end pregnancies. respondents may not e.g. —— agree to that choice but that does not give them a reason to uphold the scheme. ., ., , scheme. ruling against respondents _ scheme. ruling against respondents on - scheme. ruling againstl respondents on standing scheme. ruling...
0
0.0
Mar 11, 2024
03/24
by
BBCNEWS
tv
eye 0
favorite 0
quote 0
india is the fda �*s fifth largest trading partner with a 2—way trade talking about $23 billion in 2023. there is a huge trade deficit where the imports into india or more than 20% than the exports coming out of india to these countries and this deal will likely light of this trade deficit but they are hoping the investments will create more economic activity and create about 1 economic activity and create about1 million economic activity and create about1millionjobs economic activity and create about1 millionjobs in the world �*s fastest growing economy. the first free trade agreement with the european block into her side and the other big trade deal is with the wider european union as well as with the united kingdom have languished for years now. the indian and uk are negotiating a deal but not likely to conclude anytime soon. ., , , . soon. that is the picture there. so what will this mean for those european economies? let's hear from jane foley, head of fx strategy at rabobank. we heard the impact on india, what will this mean for the european side? fir what will this mean for th
india is the fda �*s fifth largest trading partner with a 2—way trade talking about $23 billion in 2023. there is a huge trade deficit where the imports into india or more than 20% than the exports coming out of india to these countries and this deal will likely light of this trade deficit but they are hoping the investments will create more economic activity and create about 1 economic activity and create about1 million economic activity and create about1millionjobs economic activity and...
0
0.0
Mar 26, 2024
03/24
by
BBCNEWS
tv
eye 0
favorite 0
quote 0
case was brought by a group called the alliance for hippocratic medicine, which is challenging the fda's 24—year—old decision to approve the drug. the high court in london says it will allow wikileaks founderjulian assange to appeal his extradition, if washington does not provide certain assurances about his human rights. the court has given the us until april the 16th to assure him that he would not face the death penalty. israel recalls its negotiators from mediation talks in doha after concluding that discussions with hamas are "at a dead end". it comes as the us repeated its concerns that the number of civilian casualties is too high — and their opposition to an expanded assault within rafah. a new yorkjudge places donald trump under a gag order ahead of his criminal hush money case that begins on the 15th of april. he is barred from making public statements about court staff, jurors, witnesses and lawyers in the district attorney's office — or theirfamilies. when the francis scott key bridge in baltimore was opened in 1977, it was hailed an "extraordinary engineering accompl
case was brought by a group called the alliance for hippocratic medicine, which is challenging the fda's 24—year—old decision to approve the drug. the high court in london says it will allow wikileaks founderjulian assange to appeal his extradition, if washington does not provide certain assurances about his human rights. the court has given the us until april the 16th to assure him that he would not face the death penalty. israel recalls its negotiators from mediation talks in doha after...
0
0.0
Mar 12, 2024
03/24
by
BLOOMBERG
tv
eye 0
favorite 0
quote 0
>> the fda approval gives them an additional argument that this is for other diseases. this is extremely important. this creates an effort. turning to holdings, -- along with the drugmaker. tom: what is the competitive threat right now? we know eli lilly is wrapping up its efforts around it. is there a consequential challenge this year? >> absolutely. they have the weight loss market to themselves for a couple of years, but now they are facing competition from eli lilly. these companies have known each other and been competitors in the diabetes space. people see these two companies duking it out. tom: bloomberg's naomi, thank you with the indeed for novo holdings as they build out there expansion and the market for weight loss drugs. i will be speaking with novo holdings ceo at 9:30 a.m., so tune in. to france where european elections are being seen as a dry run for the 2027 presidential race. marie is ahead with her party willing momentum, but is there anything emmanuel macron can do? let's get more from bloomberg's anya. why is it crunch time for emmanuel macron? we a
>> the fda approval gives them an additional argument that this is for other diseases. this is extremely important. this creates an effort. turning to holdings, -- along with the drugmaker. tom: what is the competitive threat right now? we know eli lilly is wrapping up its efforts around it. is there a consequential challenge this year? >> absolutely. they have the weight loss market to themselves for a couple of years, but now they are facing competition from eli lilly. these...
0
0.0
Mar 7, 2024
03/24
by
BLOOMBERG
tv
eye 0
favorite 0
quote 0
came to you and said you would be great to be the secretary of health and human services, head of the fda or something, what would you say? dr. narashimhan: i would think hard about it. at the moment he would feel like a very daunting task given the politics, but on the flipside i think public service has so much power. if it's in the right context, you can do a lot of good for the world. but i think it's very context dependent. as you know, it can be a very short time and some of these roles with some of the recent cabinet members. david: suppose i said i'm a stock market picker and i want to buy good stocks in companies that will grow. why should i want to invest in the pharmaceutical industry? will it continue to grow as last year? and your own company, good growth prospects the next couple of years? dr. narashimhan: we do, we signed up for a 5%-plus growth and 40% both in markets over time. i think the biggest investment is a science. most of the last century we were only giving people pills and small molecule drugs. then we discovered we had this whole world of biologics and we could
came to you and said you would be great to be the secretary of health and human services, head of the fda or something, what would you say? dr. narashimhan: i would think hard about it. at the moment he would feel like a very daunting task given the politics, but on the flipside i think public service has so much power. if it's in the right context, you can do a lot of good for the world. but i think it's very context dependent. as you know, it can be a very short time and some of these roles...
0
0.0
Mar 23, 2024
03/24
by
BLOOMBERG
tv
eye 0
favorite 0
quote 0
came to you and said you would be great to be the secretary of health and human services, head of the fda or something, what would you say? dr. narashimhan: i would think hard about it. at the moment, it would feel like a very daunting task, given the politics, but on the flipside, i do think public service has so much power. i think, if you are the right context, you can do a lot of good for the world. but i think it's very context dependent. as you know, it can be a very short time in some of these roles with some of the recent cabinet members. david: suppose i said i'm a stock market picker, and i want >> the preceding was a paid program. the opinions and views expressed do not reflect those of bloomberg lp, its affiliates, or its employees. to be buying good stocks in companies that will grow. why should i want to invest in the pharmaceutical industry? is it going to continue to grow, as it did last year? what about your own company? do you think it will have good growth prospects the next couple of years? dr. narashimhan: we do, we signed up for a 5%-plus growth and 40% both in marke
came to you and said you would be great to be the secretary of health and human services, head of the fda or something, what would you say? dr. narashimhan: i would think hard about it. at the moment, it would feel like a very daunting task, given the politics, but on the flipside, i do think public service has so much power. i think, if you are the right context, you can do a lot of good for the world. but i think it's very context dependent. as you know, it can be a very short time in some of...
0
0.0
Mar 12, 2024
03/24
by
BLOOMBERG
tv
eye 0
favorite 0
quote 0
they are reviewing the fda's action and whether they will cover the treatments. many medicare programs are already covering similar drugs for weight loss. asking elon musk if he would like to buy truth social. another high-profile discussion between the two. earlier they met in florida as the former president binds up motors for the election. elon musk said he is not donating money to either candidate for president. jonathan: more data about 15 minutes away. >> you might get a stronger-than-expected inflation the bird today, but extrapolating that out. jonathan: that conversation is coming up next. good morning. ♪ okay y'all we got ten orders coming in... big orders! starting a business is never easy, but starting it eight months pregnant... that's a different story. i couldn't slow down. we were starting a business from the ground up. people were showing up left and right. and so did our business needs the chase ink card made it easy. when you go for something big like this, your kids see that. and they believe they can do the same. earn unlimited 1.5% cash ba
they are reviewing the fda's action and whether they will cover the treatments. many medicare programs are already covering similar drugs for weight loss. asking elon musk if he would like to buy truth social. another high-profile discussion between the two. earlier they met in florida as the former president binds up motors for the election. elon musk said he is not donating money to either candidate for president. jonathan: more data about 15 minutes away. >> you might get a...
0
0.0
Mar 15, 2024
03/24
by
BLOOMBERG
tv
eye 0
favorite 0
quote 0
the company gets accelerated fda approval. a lot of analysts are putting a price tag on this, something like multibillion, 5 billion, but what is more important, potentially, is this is a drug they could help millions of people world wild -- worldwide with the disease. this is good news not just for shareholders. katie: nice to end on an up note. thank you. bitcoin minor marathon digital buying a new data center in texas. we will get the details with fred teal. this is bloomberg. ♪ thanks to avalara, we can calculate sales tax automatically. avalarahhhhhh what if tax rates change? ahhhhhh filing sales tax returns? ahhhhhh business license guidance? ahhhhhh -cross-border sales? -ahhhhhh -item classification? -ahhhhhh does it connect with acc...? ahhhhhh ahhhhhh ahhhhhh katie: marathon digital is increasing its bitcoin footprint, announcing it will buy a data center in garden city, texas. all the while, bitcoin retreating from its latest record highs. risk appetite wobbles heading into the weekend. joining us is fred thiel, ce
the company gets accelerated fda approval. a lot of analysts are putting a price tag on this, something like multibillion, 5 billion, but what is more important, potentially, is this is a drug they could help millions of people world wild -- worldwide with the disease. this is good news not just for shareholders. katie: nice to end on an up note. thank you. bitcoin minor marathon digital buying a new data center in texas. we will get the details with fred teal. this is bloomberg. ♪ thanks to...
0
0.0
Mar 8, 2024
03/24
by
BLOOMBERG
tv
eye 0
favorite 0
quote 0
the fda says it will hold a hearing on the pharma giant's drugs to determine how safe the treatment is. it was expected to be approved this month. attire fell off a boeing jet sure the after take off yesterday from san francisco. united airlines flight was delivered to lax after the incident with no injuries reported. vittoria secret is out of the bag. the laundry maker is making a surprise warning to investors that it expects sales to drop this year as turnaround efforts have failed to take shape. follow the latest company buzz on tren go on your bloomberg terminal. coming up, i read on the morning jobs report from construction. the industry facing a lot of news around jobs in the manufacturing front. we will speak to president and ceo up next. this is bloomberg. ♪ ♪ how am i going to find a doctor when i'm hallucinating? what about zocdoc? so many options. yeah, and dr. xichun even takes your sketchy insurance. xi-chun, xi-chun, xi-chun! you've got more options than you know. book now. thanks to avalara, we can calculate sales tax automatically. avalarahhhhhh what if tax rates ch
the fda says it will hold a hearing on the pharma giant's drugs to determine how safe the treatment is. it was expected to be approved this month. attire fell off a boeing jet sure the after take off yesterday from san francisco. united airlines flight was delivered to lax after the incident with no injuries reported. vittoria secret is out of the bag. the laundry maker is making a surprise warning to investors that it expects sales to drop this year as turnaround efforts have failed to take...
0
0.0
Mar 28, 2024
03/24
by
BLOOMBERG
tv
eye 0
favorite 0
quote 0
the company winning fda of for a new drug that treats a role -- rare form of high blood pressure. drug clearance coming at a critical time for them as they prepare to lose market exclusivity for their cancer drug, keep truth. rob joins us for more. good morning. how much of a rake through is this? rob: this is really, we think, something special. the disease we hopefully think we will be able to make a difference is is pulmonary hypertension. it's a rare disease, not well-known but devastating. it's a disease that primarily affects women in the prime of life, age 30 to 60. mortality rates of 43% in five years. you can imagine impact not only to the patient, but to the family of people who otherwise are in the prime of life, really tragic. thankfully and hopefully this will make a difference. this drug, we are now bringing it forward, it's a biologic and first in class medicine. a new mechanism of action with an active signaling inhibitor that potentially remodels the blood vessels, the arterial vessels, allowing them to open up. ph causes your blood vessels in your lungs to thicke
the company winning fda of for a new drug that treats a role -- rare form of high blood pressure. drug clearance coming at a critical time for them as they prepare to lose market exclusivity for their cancer drug, keep truth. rob joins us for more. good morning. how much of a rake through is this? rob: this is really, we think, something special. the disease we hopefully think we will be able to make a difference is is pulmonary hypertension. it's a rare disease, not well-known but devastating....
0
0.0
Mar 27, 2024
03/24
by
BLOOMBERG
tv
eye 0
favorite 0
quote 0
up 5% on an fda approval. countdown to the open kicks in now. >> everything you need to get sent for the start of u.s. trading. this is bloomberg the open with jonathan ferro. manus: coming up in the show
up 5% on an fda approval. countdown to the open kicks in now. >> everything you need to get sent for the start of u.s. trading. this is bloomberg the open with jonathan ferro. manus: coming up in the show
0
0.0
Mar 12, 2024
03/24
by
BLOOMBERG
tv
eye 0
favorite 0
quote 0
the fda has approved a weight loss drug for heart disease patients, a move that could open the door for medicare coverage since it raises the question of whether medicare could now cover the cost for patients with a history of heart disease. about one third of state medicaid programs currently cover the use of wegovy and other glp1 drugs for weight loss. jonathan: thank you. up next, targeting 2% inflation. >> i do think that we are seeing enough of those inflations for a cut in june. let's say retail sales are weaker, we have a soft inflation report. then i think we start pressing that rate cut again. jonathan: that conversation just around the corner. live from new york, this is bloomberg. ♪ ...whoa... you've got all kinds of bright ideas, that your customers need to know about. constant contact makes it easy. with everything from managing your social posts, and events, to email and sms marketing. constant contact delivers all the tools you need to help your business grow. get started today at constantcontact.com constant contact. helping the small stand tall. get help reaching your
the fda has approved a weight loss drug for heart disease patients, a move that could open the door for medicare coverage since it raises the question of whether medicare could now cover the cost for patients with a history of heart disease. about one third of state medicaid programs currently cover the use of wegovy and other glp1 drugs for weight loss. jonathan: thank you. up next, targeting 2% inflation. >> i do think that we are seeing enough of those inflations for a cut in june....
0
0.0
Mar 6, 2024
03/24
by
BLOOMBERG
tv
eye 0
favorite 0
quote 0
they have asked the fda to issue a recall for treatments that contain inso peroxide. jonathan: a trump/bided rematch. >> they call it super tuesday for a reason. that conversation up next. live from new york city, this is bloomberg. bloomberg. hey you, with the small business... ...whoa... you've got all kinds of bright ideas, that your customers need to know about. constant contact makes it easy. with everything from managing your social posts, and events, to email and sms marketing. constant contact delivers all the tools you need to help your business grow. get started today at constantcontact.com constant contact. helping the small stand tall. get help reaching your goals with j.p. morgan wealth plan, a digital money coach in the chase mobile® app. use it to set and track your goals, big and small... and see how changes you make today... could help put them within reach. from your first big move to retiring poolside - and the other goals along the way. wealth plan can help get you there. ♪ j.p. morgan wealth management. godaddy airo. creates a logo, website, ev
they have asked the fda to issue a recall for treatments that contain inso peroxide. jonathan: a trump/bided rematch. >> they call it super tuesday for a reason. that conversation up next. live from new york city, this is bloomberg. bloomberg. hey you, with the small business... ...whoa... you've got all kinds of bright ideas, that your customers need to know about. constant contact makes it easy. with everything from managing your social posts, and events, to email and sms marketing....
0
0.0
Mar 8, 2024
03/24
by
BLOOMBERG
tv
eye 0
favorite 0
quote 0
evaluate the site safety and efficacy of the treatment prayed it's a surprise announcement from the fda which is why it is expected to rule on approving the drug in the coming weeks. krista lean opposed to secure support for a second five-year term as imf managing director. she has the backing of -- to ensure the success of any potential bid. working in pursuit of us second term understanding she is the support of france and germany. the chipmaker is up 3% in the premarket trade and puts it on track for seven straight days of gains. it also added more than $1 trillion in value this year alone. inching closer to surpassing apple's market cap. the market cap is fallen significantly but would make it the world's second-biggest company. that's your bloomberg brief. jonathan: the man who shall not be named. >> my predecessor. my predecessor. my predecessor. it never occurred to my predecessor. failing the most basic presidential duty. jonathan: i said earlier this was like baltimore for democrats. we might get a year of this. from new york city this is bloomberg. ♪ j.p. morgan wealth manag
evaluate the site safety and efficacy of the treatment prayed it's a surprise announcement from the fda which is why it is expected to rule on approving the drug in the coming weeks. krista lean opposed to secure support for a second five-year term as imf managing director. she has the backing of -- to ensure the success of any potential bid. working in pursuit of us second term understanding she is the support of france and germany. the chipmaker is up 3% in the premarket trade and puts it on...
0
0.0
Mar 21, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
we have the algorithm, it's fda approved. and what we found in the clinical studies is that surgeons were missing 26% of the polyps. and again, it's not that they're doing something wrong. other than being human. when they're doing eight procedures a day, in some cases ten, their eyes get tired and they miss things. and some things are almost impossible to see with the naked eye. and the ai picks it up and it doesn't get tired. >> we keep learning how ai is better than humans. they don't get tired. they don't make these mistakes that can be life-threatening. you guys are doing some incredible hypertension stuff that could make it for -- now fda approved that could make it so people who don't like to take their pmedicine because they can't see that they have hypertension you save their lives for them. >> right. i think, jim, this new hypertension procedure we call simplicity could be the biggest thing that we've ever done. we've been working on it for 15 years. as you mentioned, just got the fda approval. and what it is, it's
we have the algorithm, it's fda approved. and what we found in the clinical studies is that surgeons were missing 26% of the polyps. and again, it's not that they're doing something wrong. other than being human. when they're doing eight procedures a day, in some cases ten, their eyes get tired and they miss things. and some things are almost impossible to see with the naked eye. and the ai picks it up and it doesn't get tired. >> we keep learning how ai is better than humans. they don't...
0
0.0
Mar 27, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
two other companies have fda clearance to conduct human studies. about 40 implants, a federal study in 2022 looking across this category. and documented about 40 cases where these devices had been implanted in human subjects. this is a technology that we have been working on for a while, neuralink is another entrant into the space i do believe it has promise. the ability to read electrical waves off of the brain and be able to correlate how those would line up with certain outputs, certain intended outputs is a technology that we have been working on for a long time we collectively meaning the research community a lot of this is based on machine learning you're looking at patterns for the electrical impulses put off by the brain and trying to determine how those would translate into intended actions and then trying to stimulate those actions to -- either through a computer or a mechanized device that the user may wear to try to restore some partial function for someone who is a quadriplegic. these technologies have a lot of promise. other companies
two other companies have fda clearance to conduct human studies. about 40 implants, a federal study in 2022 looking across this category. and documented about 40 cases where these devices had been implanted in human subjects. this is a technology that we have been working on for a while, neuralink is another entrant into the space i do believe it has promise. the ability to read electrical waves off of the brain and be able to correlate how those would line up with certain outputs, certain...
0
0.0
Mar 6, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
former fda commissioner dr. scott gottlieb joins us now. great to see you. we had a heated discussion surrounding is this yesterday, and we had some question marks around the eye popping numbers that deese outlines, and you took issue with those numbers. what, in your opinion, did he miss? >> there's no question this is going to cost medicare a lot of money, not nearly what was estimated in the op-ed. they wrongly used list price to make their assumptions on what the cost would be rather than the net price. we know discounting is heavy in the market, on the order of 40 to 60% between wegovy. they wrongly assumed it was approved under a biological. it was approved under a drug application, it's subject to price negotiation within the ira, within medicare, and it's probably going to go on list this year, so it's probably going to be subject to negotiated price as early as 2027. and some analysts on wall street are estimating that. and so the notion of the op-ed was that we need to extend the price negotiation under the ira to encompass these drugs because othe
former fda commissioner dr. scott gottlieb joins us now. great to see you. we had a heated discussion surrounding is this yesterday, and we had some question marks around the eye popping numbers that deese outlines, and you took issue with those numbers. what, in your opinion, did he miss? >> there's no question this is going to cost medicare a lot of money, not nearly what was estimated in the op-ed. they wrongly used list price to make their assumptions on what the cost would be rather...
0
0.0
Mar 27, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
we close back to pippa stevens. >> merck is popping after the fda approved the pharmaceutical companies drug to treat a rare and deadly lung disease. the approval is a big win as the pharma firm looks to diversify after his blockbuster cancer drug sees a shrinking market share. after announcing plans to move three of its vaccines to final stage trials. this update brings moderna closer to having products on the market beyond just it's covid shot, which is seen plunging demand. >> appreciate that. teslas there's driving higher. we'll find out what's behind rserads pop and what brian getn h to tell me and what he had to say about the evening a. that's coming up when closing bell is coming right back. boring does. great job astro-persons. over. boring is the jumping off point for all the un-boring things we do. boring makes vacations happen, early retirements possible, and startups start up. because it's smart, dependable, and steady. all words you want from your bank. taking chances is for skateboarding... and gas station sushi. not banking. that's why pnc bank strives to be boring with y
we close back to pippa stevens. >> merck is popping after the fda approved the pharmaceutical companies drug to treat a rare and deadly lung disease. the approval is a big win as the pharma firm looks to diversify after his blockbuster cancer drug sees a shrinking market share. after announcing plans to move three of its vaccines to final stage trials. this update brings moderna closer to having products on the market beyond just it's covid shot, which is seen plunging demand. >>...
0
0.0
Mar 7, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
furyk, the ftc, and the fda. two out of three, good. two out of three not responsive, i think they have upped their reservations. anti-oil and gas, ftc, i'll leave that to david. fda is gold standard and has not changed through any administration. so they're not going to -- we're the best. and i just really think that we have to be careful saying oh, they're going to like viking. they love lilly. because lilly has a great safety record. >> as for novo, that's an all-time high this morning. a lot of pieces lately, jim, talking about how it's changed not just the danish economy but the european economy. >> frank holland had an excellent person from citi about the new magnificent seven is the foreign language version, what i found is interesting is it starts with lvmh. they have companies over there. schneider electric. you know schneider? >> i do. >> mr. big shot. >> wasn't schneider the super on a sitcom in the '70s. >> one day at a time. >> that's incredible. >> can i tell you some of mnuchin's movies that were good? >> what's the ben a
furyk, the ftc, and the fda. two out of three, good. two out of three not responsive, i think they have upped their reservations. anti-oil and gas, ftc, i'll leave that to david. fda is gold standard and has not changed through any administration. so they're not going to -- we're the best. and i just really think that we have to be careful saying oh, they're going to like viking. they love lilly. because lilly has a great safety record. >> as for novo, that's an all-time high this...
0
0.0
Mar 8, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
the fda has approved wegovey for cardiovascular risk reduction and people with over weight or obesity and established cardiovascular disease. nov norshares pairing the losses, down on the day but keep an eye on nov nordisk. have a great day and we will see you on monday. the first law of thermodynamics states that energy cannot be created or destroyed. (♪♪) but it can be passed on to the next generation. (♪♪) it's odd how in an instant things can transform. slipping out of balance into freefall. i'm glad i found stability amidst it all. gold. standing the test of time. the future is not just going to happen. you have to make it. and if you want a successful business, all it takes is an idea, and now becomes the future where you grew a dream into a reality. the all new godaddy airo. put your business online in minutes with the power of ai. they're waiting for you. hey, do you have a second? they're all expecting more. more efficiency. more benefits. more growth. when you realize you can give your people everything, and more. thank you very much. [applause] ask, "now what?" here
the fda has approved wegovey for cardiovascular risk reduction and people with over weight or obesity and established cardiovascular disease. nov norshares pairing the losses, down on the day but keep an eye on nov nordisk. have a great day and we will see you on monday. the first law of thermodynamics states that energy cannot be created or destroyed. (♪♪) but it can be passed on to the next generation. (♪♪) it's odd how in an instant things can transform. slipping out of balance into...
0
0.0
Mar 15, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
the fda approving a drug from mardrugal pharmaceuticals for liver disease. it will be available in april. novo nordisk and eli lilly are testing their drugs to treat as well. >>> taylor swift has sold out stadiums worldwide and ruled the box office with the concert film and now brought "eras tour" to disney plus. if you are a true swiftie, you watched it all the way through for the second time. welcome to "worldwide exchange." it takes that long. landing the tour was a major win for disney which paid $75 million for the streaming rights. will it be enough to move the needle for subscriber growth? let's bring in the media and business writer for the hollywood reporter. alex, thank you for being here. this is big for disney plus. it is huge. it is a caultural revolution fo taylor swift. is this going to be the catalyst that disney needs to get disney plus subscribers going again? >> taylor swift is the biggest thing in entertainment. i think the eras tour movie can absolutely drive new sub descrisubdescribe subscribe arers to disney plus. as they move advertis
the fda approving a drug from mardrugal pharmaceuticals for liver disease. it will be available in april. novo nordisk and eli lilly are testing their drugs to treat as well. >>> taylor swift has sold out stadiums worldwide and ruled the box office with the concert film and now brought "eras tour" to disney plus. if you are a true swiftie, you watched it all the way through for the second time. welcome to "worldwide exchange." it takes that long. landing the tour...
0
0.0
Mar 12, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
the first fda-cleared at-home skin tag remover clinically proven to remove skin tags safely in as little as one treatment. >>> welcome back to "worldwide exchange." we have the morning call sheet. jefferies upgrading carvana. it will result in a more attr attractive risk-reward scenario. >>> and raymond jameses upgrade coinbase. the stock momentum may persist. >>> we have a strong move on microstrategy up to $1,810 per share. the bets on bitcoin and the proven strategy to drive out sized shareholder returns. >>> now shares of arm holdings are closing down yesterday after the a.i. stocks pulled back in recent days. arm faces a big test today as they post-ipo lock-up period expires. it is valis valued at 150%. arm has an unusual situation. 90% of the stock is owned by softbank. let's talk more about this with ben harburg, the managing partner at the firm investing in uber and airbnb. ben, great to have you here. >> thank you. >> we talked about it. you have experience in the high profile ipos. uber and nio being some of them. what do you expect today and how does this look different? softb
the first fda-cleared at-home skin tag remover clinically proven to remove skin tags safely in as little as one treatment. >>> welcome back to "worldwide exchange." we have the morning call sheet. jefferies upgrading carvana. it will result in a more attr attractive risk-reward scenario. >>> and raymond jameses upgrade coinbase. the stock momentum may persist. >>> we have a strong move on microstrategy up to $1,810 per share. the bets on bitcoin and the...
0
0.0
Mar 15, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
for more on this, we want to bring in former fda commissioner dr. scott gottlieb, a member of imlumina and pfizer and cnbc contributor. dr. gottlieb, i don't know we have done enough to explain this situation and describe to people what is really happening. this is kind of catastrophic. what happened? >> it is very pervasive across the entire healthcare system. this is one of the largest facilitators of health claims and medical claims in the country. they handle about 15 billion claims a year, totalling around $1.5 trillion. basically a third of the entire healthcare system, we have a $4.5 trillion healthcare system. what this system does is it handles claims not just for united healthcare, but for other insurers as well. doctors will subscribe to this system, contract with it. and it will tell them whether or not patients are eligible to receive a prescription or whether they're eligible against their insurance plan to receive a certain procedure, what the cost will be, what the provider will be paid, what the co-pay to the patient will be. so, a
for more on this, we want to bring in former fda commissioner dr. scott gottlieb, a member of imlumina and pfizer and cnbc contributor. dr. gottlieb, i don't know we have done enough to explain this situation and describe to people what is really happening. this is kind of catastrophic. what happened? >> it is very pervasive across the entire healthcare system. this is one of the largest facilitators of health claims and medical claims in the country. they handle about 15 billion claims a...
0
0.0
Mar 19, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
can scour data to identify natural candidates for the trial instead of just posting the trial to the fda website the lame way it's done now. then they can use a.i. to see if they have the right people who commit to the rules of the trial. many i sources believe a process that might take two or three years to get off the ground could take three months. meanwhile the knowledge nvidia can bring to the actual drug development process to knowing the best way to make it, something a computer is much better than human, that's a game changer. as someone trying to help invent drugs myself, i can't tell you how big this is. there's so many publicly traded drug companies and they face the same dilemma to try and tackle serious illnesses. with nvidia's speed and superior earning, it becomes a lot more easy. they may not solve the problem of a baby's bad heart or dysfunctional brain, but there are hundreds of other illnesses that could be treated better using nvidia's machines to make it worthwhile for the drug companies to make riskier bets on harder to treat diseases. that's a win, not just for you
can scour data to identify natural candidates for the trial instead of just posting the trial to the fda website the lame way it's done now. then they can use a.i. to see if they have the right people who commit to the rules of the trial. many i sources believe a process that might take two or three years to get off the ground could take three months. meanwhile the knowledge nvidia can bring to the actual drug development process to knowing the best way to make it, something a computer is much...
0
0.0
Mar 4, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
the $436 billion package funds agriculture and transportation and hud and commerce and interior and fda and v.a. and it includes the provision to block oil sales from the u.s. reserves to china. the house plans to vote first on the measure before president biden's state of the union address on thursday. >>> ark house is raising the stake for macy's. they are offering to buy stock they don't already own for $24 a share or 14% more than the previous bid of $21 a share. arkhouse made the offer in december, but it was rejected due to concerns over the deal's financing evaluation. macy's said the board which review the latest proposal. >>> and shares of super microcomputer and deckers outdoor are jumping. the companies will join the s&p 500 on march 18th. it will replace whirlpool and xion will which take over in the index. super micro has seen the stock more than triple this year pushing the market cap above $50 billion. >> you can see shares up double digits right now . silvana, thank you. >>> turning attention now to oil. opec plus countries offering to extend the production until mid-yea
the $436 billion package funds agriculture and transportation and hud and commerce and interior and fda and v.a. and it includes the provision to block oil sales from the u.s. reserves to china. the house plans to vote first on the measure before president biden's state of the union address on thursday. >>> ark house is raising the stake for macy's. they are offering to buy stock they don't already own for $24 a share or 14% more than the previous bid of $21 a share. arkhouse made the...
0
0.0
Mar 19, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
the first fda-cleared at-home skin tag remover clinically proven to remove skin tags safely in as little as one treatment. what is cirkul? cirkul is the fuel you need to take flight. cirkul is the energy that gets you to the next level. cirkul is what you hope for when life tosses lemons your way. cirkul, available at walmart and drinkcirkul.com. >>> welcome back. time for the morning call sheet. mizuho covering lowe's which is well positioned to catch pent-up demand over home depot with the higher diy exposure. >>> another initiation from jefferies on zoom. new products should provide a tailwind. >>> a price target increase from micron from ubs moving it from $120 a share. ubs expects higher lower will translate to micron being able to hold a higher multiple. >>> time for the global briefing. we start with news with the bank of japan ending the only negative rate regime and hiking rates for the first time since 2 2007. it will buy government bonds worth the same amount of $139 billion a month. >>> and evergrande boosted sales in the years prior to the collapse. it faces a fine of $500 m
the first fda-cleared at-home skin tag remover clinically proven to remove skin tags safely in as little as one treatment. what is cirkul? cirkul is the fuel you need to take flight. cirkul is the energy that gets you to the next level. cirkul is what you hope for when life tosses lemons your way. cirkul, available at walmart and drinkcirkul.com. >>> welcome back. time for the morning call sheet. mizuho covering lowe's which is well positioned to catch pent-up demand over home depot...
0
0.0
Mar 8, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
. >> eli lilly dropping after the fda surprised move to delay rate reaction on the treatment of als while expected to be approved this month. bitcoin at new highs, topping $70,000 for the first time after surpassing the covid-era high. the recent crypto mania lifting coinbase, goldman upgraded the stock to neutral. >>> next, more on the intraday reversal for stocks with jeremy siegel. his first take on the jobs report and on the rally, what is happening in the stocks. you are watching closing bell on cnbc. complexity. healthcare payments are filled with it. wasted time, inadequate resources. confusion about the cost of care and how to afford it. it's time to simplify. waystar's technology is the way to make healthcare payments more human. the way for providers to prioritize care and improve margins. the way for patients to have clarity and trust. the way to care for healthcare payments. waystar. the way forward. (grunting) at morgan stanley, old school hard work meets bold new thinking. (laughter) at 88 years old, we still see the world with the wonder of new eyes, helping you discover un
. >> eli lilly dropping after the fda surprised move to delay rate reaction on the treatment of als while expected to be approved this month. bitcoin at new highs, topping $70,000 for the first time after surpassing the covid-era high. the recent crypto mania lifting coinbase, goldman upgraded the stock to neutral. >>> next, more on the intraday reversal for stocks with jeremy siegel. his first take on the jobs report and on the rally, what is happening in the stocks. you are...
0
0.0
Mar 27, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
meanwhile sharess merck are jumping ahead of the opening after the fda approved a drug that helps with a progressive lung disease merck expects the treatment to be available in select specialty pharmacies in the u.s. by the end of next month. >>> and shares of robinhood also rising after it unveiled its first ever credit card the retail trading firm is entering the competitive space with its robinhood gold card offering 3% back on all cat fwooirs. the card will require a robin hod gold membership, which runs $5 per month or $50 annually, frank. >> silvana, thank you very much. we'll see you a bit later in the show. >>> we've got a lot more to come on "worldwide exchange" including the w.e.x. word of the day. >>> first china's ceo sits down and talks about the roll out of policies. >>> and game over for shares of gamestop as the retailer gets crushed at the open. >>> later, u.p.s. shareholders asking what can brown do for me as the stock gets hard during its investor day how ceo carol tome says she plans to turn things around. a busy day ahead when "worldwide exchange" returns. so this
meanwhile sharess merck are jumping ahead of the opening after the fda approved a drug that helps with a progressive lung disease merck expects the treatment to be available in select specialty pharmacies in the u.s. by the end of next month. >>> and shares of robinhood also rising after it unveiled its first ever credit card the retail trading firm is entering the competitive space with its robinhood gold card offering 3% back on all cat fwooirs. the card will require a robin hod gold...
0
0.0
Mar 28, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
the first fda-cleared at-home skin tag remover clinically proven to remove skin tags safely in as little as one treatment. >>> sometimes i feel like everyone in this business is always fighting the last war. how many times have you heard that this market is led by seven stocks and nothing else matters? i mean, that is still the conventional wisdom even though it has not been true for the last five months. we close out the best first quarter in ages. it was a classic continuation of the last two months of 2023. office stocks were crushed by high interest rates came roaring back. with apple at 11% and tesla with 29%, the mag 7 didn't even surpass the averages. but what's been working? the top five stocks, i bet you would be shocked because it's the most broad-based companies i can recall. disney propelled by nelsons proxy fight. it has put a gun to managements had. i think that's what disney has gotten its act together. although i don't think management shares that position. reasonable people can disagree. i have been pounding the table on this one for the investing club for ages. it's gre
the first fda-cleared at-home skin tag remover clinically proven to remove skin tags safely in as little as one treatment. >>> sometimes i feel like everyone in this business is always fighting the last war. how many times have you heard that this market is led by seven stocks and nothing else matters? i mean, that is still the conventional wisdom even though it has not been true for the last five months. we close out the best first quarter in ages. it was a classic continuation of the...
0
0.0
Mar 8, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
today, the fda expanded the label to include helping to prevent heart attacks the insurers would think that is great. i still love lily. the investing club you will know that, they put in a lot of money of scaling up production, that matters at this moment and the rest of the pipeline is strong. no denying this will be there for some time. that is why i feel that you can not go wrong with either of the stocks. there is more than enough room for both of them. now, up 28% year to date and 88% over the past 12 months, i bet it has more room to run. next up, citi calls out the asml company. their equipment is the size of a bus. okay. now, a city bus. this is another industry with a handful of major players with limited competition, even here asml stands out for being reliable. it could be a 31% gain since the beginning of the new year. when asml reported in january the net bookings coming in at 9.2 billion euros: that is up 258% since the previous quarter. staggering pick up in new orders, that is what wall street likes, the u.s. is trying to block the chinese from getting asml's best mach
today, the fda expanded the label to include helping to prevent heart attacks the insurers would think that is great. i still love lily. the investing club you will know that, they put in a lot of money of scaling up production, that matters at this moment and the rest of the pipeline is strong. no denying this will be there for some time. that is why i feel that you can not go wrong with either of the stocks. there is more than enough room for both of them. now, up 28% year to date and 88%...
0
0.0
Mar 22, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
the first fda-cleared at-home skin tag remover clinically proven to remove skin tags safely in as little as one treatment. >> it's time. time for the lightning round. the lightning round is over. are you ready? thomas. >> cramer. what a great national treasure you are. thank you very much for all you do for us. >> thanks a lot. we had a great time. how can i help you? >> r jf. what are your thoughts? >> it's a horse. higher than j.p. morgan so i say it's too late. we missed it. find the next one. jeremiah and california. >> thanks for taking my call. this stock has been bouncing up and down. >> i like arm very much. it looks like it's finally going. i think you have a good situation there. michael in georgia. >> first-time caller. my question is around unity software. >> i would've told you to sell the stock. you can anymore because jim whitehurst is now in charge. whitehurst is a winner. i change my mind because he's running it. let's go to george. >> i'm calling on c rk. >> i think there's so many that are better that i have to refer you to get ctr rate which is a better situation. let
the first fda-cleared at-home skin tag remover clinically proven to remove skin tags safely in as little as one treatment. >> it's time. time for the lightning round. the lightning round is over. are you ready? thomas. >> cramer. what a great national treasure you are. thank you very much for all you do for us. >> thanks a lot. we had a great time. how can i help you? >> r jf. what are your thoughts? >> it's a horse. higher than j.p. morgan so i say it's too late....
0
0.0
Mar 4, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
the fda is not saying, oh, let's get those guys. they should say, listen, lilly's got it. lilly's got is zepbound and people are not getting sick, even though there's 42 things that could go wrong. viking cruise lines is coming public. viking versus viking, david. >> viking versus viking, yeah. >> like royal caribbean. >> love it. it's great. >> you like the 13th row down, the 13th deck? >> are there 13 decks? >> i don't know. where's dicaprio? >> steerage. third class. >> steerage. yes. >> i was just trying to find my notes. >> what are you looking for? >> tesla shares are down another 3%. shipments from the factory in shanghai, lowest level in more than a year. a lot of stories of late about the strength of chinese -- >> byd. >> -- automakers, and obviously, ev is a large portion of that. stories about how they're going to flood the market in markets that will take them around the world, because the chinese economy is weak. you do not have the level of domestic consumption that would be there to actually buy all of these automobiles. so -- >> many of them are subsidized
the fda is not saying, oh, let's get those guys. they should say, listen, lilly's got it. lilly's got is zepbound and people are not getting sick, even though there's 42 things that could go wrong. viking cruise lines is coming public. viking versus viking, david. >> viking versus viking, yeah. >> like royal caribbean. >> love it. it's great. >> you like the 13th row down, the 13th deck? >> are there 13 decks? >> i don't know. where's dicaprio? >>...
0
0.0
Mar 27, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
at this rally in merk with the stock soaring almost 5% after last night's announcement they got the fda approval for their new hypertension drug. that is huge. not just because this is the first decent treatment option for a potentially life threatening disease. it's also good news for them because like most of big pharma it always needs new products. that's the game. last year they got over 40% of their sales from the best anti cancer drug but it'll start to go to patent in 2028. that's why they are making a lot of small, medium acquisitions. remember that we had about that? as for hypertension drug it's -- the payoff from the 11.5 -- makes pharma in 2021. so it's not just good news but great news. the management strategy is working but do not take it from me. let's check in with rob davis. welcome back. >> thank you for having me. i'm excited to be here. it's a great day for merck and patients. >> it's a pretty bleak future until today. >> you know it is. this disease and this is a rare disease. it doesn't really get a lot of attention. it's really devastating. this is a disease mainl
at this rally in merk with the stock soaring almost 5% after last night's announcement they got the fda approval for their new hypertension drug. that is huge. not just because this is the first decent treatment option for a potentially life threatening disease. it's also good news for them because like most of big pharma it always needs new products. that's the game. last year they got over 40% of their sales from the best anti cancer drug but it'll start to go to patent in 2028. that's why...
0
0.0
Mar 8, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
the fda had controversially approved the drug for use against als and a second stage trial but ow the drug has failed a stage three trial and the company is suspending it. regulators in europe had withdrawn it. >> frustrating for everyone in the als community for a potential scandal in college basketball, gambling watchdog flag again yesterday between uab and temple for unusual activity, the game open with uab as a 1.5 point favorite which ballooned as high as eight before closing with uab favored by seven no one is alleging wrongdoing but a move like that is unusual. what happened? maybe people see action on one side and decide to follow the sharp money, more nefarious possibilities include someone knowing nonpublic information about one of the teams, or worse case scenario, point shaving, uab overed the inflated spread the winning 100- 72. we reached out to ncaa and temple who both say they are reviewing it but cannot comment. >> the betting on college basketball, pro sports, is growing amazingly. it does open up suspicions sometimes when you see a spread move like that. >> that is
the fda had controversially approved the drug for use against als and a second stage trial but ow the drug has failed a stage three trial and the company is suspending it. regulators in europe had withdrawn it. >> frustrating for everyone in the als community for a potential scandal in college basketball, gambling watchdog flag again yesterday between uab and temple for unusual activity, the game open with uab as a 1.5 point favorite which ballooned as high as eight before closing with...
0
0.0
Mar 21, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
for now the surgery is not fda approved. >>> a $1.8 billion movie studio backed by actor mark wahlberg has been approved to build in las vegas, the clark county zoning commission that green lighted the joint venture between sony entertainment and howard hughes holdings yesterday. that could bring in 10,000 jobs to las vegas. and, of course, we talked to mark wahlberg last year in nevada where he was lobbying lawmakers for those film production tax breaks. they're looking forward, frank, to diversifying nevada's economy beyond gambling and beyond travel and tourism. >> all right. our contessa brewer live. >>> more ideas for your portfolio. josh gives you a sneak peek. the best stocks, the desk will discuss those nas xtomg .pmene cin much more "halftime" after this. as an independent financial advisor, i stand by these promises. as a fiduciary, i promise to be the financial steward that you and your family need. i promise to put your long-term financial well-being above any short term transaction. everyone has a big picture. my job is to help you invest in yours. [announcer] charles schw
for now the surgery is not fda approved. >>> a $1.8 billion movie studio backed by actor mark wahlberg has been approved to build in las vegas, the clark county zoning commission that green lighted the joint venture between sony entertainment and howard hughes holdings yesterday. that could bring in 10,000 jobs to las vegas. and, of course, we talked to mark wahlberg last year in nevada where he was lobbying lawmakers for those film production tax breaks. they're looking forward,...
0
0.0
Mar 8, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
the fda will delay approval for their alzheimer's drug. the stock has been a one-way freight train because of glp-1. what about now? >> i think the stock is more susceptible to market conditions than idiosyncratic conditions for itself. the stock was only down 1% on this news today. now it's down 2%. if we have a correction in the momentum factor, which has been the most significant catalyst year to date represented with semiconductors, then lilly will fall as well. the fundamental story for this company has not changed in one regard at all, and i continue to maintain position. >> jason, there's been commentary in the marketplace about streaming consolidation and who the winners and losers are going to be. barclays has a note that says it could be a bigger winner for youtube than for netflix. now i've been getting a lot of news about live sports and netflix would have the announcement with mike tyson and a fight coming up there. you own netflix. what do we think? >> i think this is an interesting call. i wouldn't be surprised if youtube is
the fda will delay approval for their alzheimer's drug. the stock has been a one-way freight train because of glp-1. what about now? >> i think the stock is more susceptible to market conditions than idiosyncratic conditions for itself. the stock was only down 1% on this news today. now it's down 2%. if we have a correction in the momentum factor, which has been the most significant catalyst year to date represented with semiconductors, then lilly will fall as well. the fundamental story...